Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

MedWellAI (MWAI) EBIT Margin (2017 - 2025)

Historic EBIT Margin for MedWellAI (MWAI) over the last 9 years, with Q3 2025 value amounting to 339.29%.

  • MedWellAI's EBIT Margin rose 509659400.0% to 339.29% in Q3 2025 from the same period last year, while for Sep 2025 it was 289.0%, marking a year-over-year decrease of 3459900.0%. This contributed to the annual value of 477.59% for FY2025, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, MedWellAI's EBIT Margin is 339.29%, which was up 509659400.0% from 37.04% recorded in Q2 2025.
  • In the past 5 years, MedWellAI's EBIT Margin registered a high of 37.04% during Q2 2025, and its lowest value of 51305.23% during Q3 2024.
  • Its 5-year average for EBIT Margin is 3067.49%, with a median of 164.91% in 2022.
  • Its EBIT Margin has fluctuated over the past 5 years, first crashed by -504500500bps in 2024, then soared by 509659400bps in 2025.
  • Quarter analysis of 5 years shows MedWellAI's EBIT Margin stood at 13.03% in 2021, then plummeted by -1166bps to 164.91% in 2022, then soared by 88bps to 19.42% in 2023, then tumbled by -2483bps to 501.65% in 2024, then surged by 32bps to 339.29% in 2025.
  • Its EBIT Margin was 339.29% in Q3 2025, compared to 37.04% in Q2 2025 and 360.22% in Q1 2025.